Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 28, 2023
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
Scott Fidel Reiterated (ACHC) at Hold and Held Target at $92 on, Feb 28th, 2023
Scott Fidel of Stephens & Co., Reiterated "Acadia Healthcare Company, Inc." (ACHC) at Hold and Held Target at $92 on, Feb 28th, 2023.
Scott has made no other calls on ACHC in the last 4 months.
There are 3 other peers that have a rating on ACHC. Out of the 3 peers that are also analyzing ACHC, 1 agrees with Scott's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Ann Hynes of "Mizuho" Maintained at Hold with Increased Target to $87 on, Thursday, December 8th, 2022
These are the ratings of the 2 analyists that currently disagree with Scott
- Ben Hendrix of "RBC Capital" Maintained at Buy with Decreased Target to $93 on, Monday, December 12th, 2022
- Joseph France of "Loop Capital" Upgraded from Hold to Strong Buy and Held Target at $95 on, Monday, December 12th, 2022
